News | October 10, 2007

Omnicell Introduces the Next Generation Central Pharmacy Automation Solution

October 11, 2007 - Omnicell Inc., a provider of system solutions to acute healthcare for improving patient safety and efficiency, said today introduced its WorkflowRx 5.0 central pharmacy automation solution.
With a new user-friendly graphical interface, the company says the Omnicell WorkflowRx 5.0 allows pharmacy staff to complete automated dispensing, unit-dose packaging and other inventory maintenance tasks simultaneously. The WorkflowRx 5.0 also increases productivity and efficiency through a unique intelligent hardware recovery management feature that frees staff to focus on direct patient care activities.
“The WorkflowRx solution provides us with the ability to manage every pharmaceutical in the hospital, whether it is stored in the central pharmacy, stocked in an automated cabinet, stored in a remote nursing destination, or in a satellite pharmacy location,” said David Grant, RPh, MBA, director of pharmacy and respiratory care, Chambersburg Hospital. “The WorkflowRx 5.0 solution is easy to use and maximizes the efficiency of pharmacists and technicians. After implementing the WorkflowRx solution, we’ve reduced our cart-fill time from 16 man-hours to 90 minutes. The result is a significantly streamlined pharmacy process with greater efficiency and patient safety and has enhanced our compliance with JHACO requirements.”
Omnicell WorkflowRx central pharmacy solutions automate the ordering, receiving, stocking, dispensing and unit-dose packaging of medications. It provides central pharmacy operations with greater patient safety and more efficient staff utilization, while decreasing medication inventory costs. The WorkflowRx 5.0 solution interfaces to Omnicell’s barcode packaging system and inventory management carousel system to manage 100 percent of the central pharmacy inventory and dispensing tasks.
Additional new features of the WorkflowRx 5.0 solution include an integrated 340B order process that tracks 340B-eligible drug usage and automatically generates 340B-specific purchase orders, allowing participating facilities to realize the benefits of 340B pricing without complicated management of drug utilization data.

For more information: www.omnicell.com

Related Content

statins, heart scan, CT scan
News | March 25, 2014
As long as inexpensive statins, which lower cholesterol, are readily available and patients do not mind taking them, it...
News | September 30, 2013
A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per month to allow...
Feature | February 21, 2013
  Time Magazine releases the dramatic findings of a months-long investigation by contributor Steven Brill into how...
Feature | April 02, 2012
It seems a picture is worth more than a thousand words for people who see evidence of coronary artery disease, the most...
News | November 18, 2011
November 17, 2011 — Westside Medical Imaging of Beverly Hills announces the availability of high resolution magnetic...
News | October 21, 2009
October 21, 2009 – King Pharmaceuticals Inc. said today the U.S. Food and Drug Administration issued a complete...
News | October 05, 2009
October 5, 2009 – A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A adenosine...
News | July 10, 2009
July 10, 2009 – New British Heart Foundation (BHF) research(1) revealed today suggests for the first time that the way...
News | April 06, 2009
April 7, 2009 - Lantheus Medical Imaging Inc. has acquired the U.S., Canadian and Australian rights to MS-325 (...
News | June 16, 2008
June 17, 2008 - One of the biggest challenges in fighting tuberculosis is simply getting patients to take their medic
Overlay Init